Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model. (29th July 2021)

• Record Type: Journal Article
• Authors: Ranea‐Robles, Pablo; Galino, Jorge; Espinosa, Lluís; Schlüter, Agatha; Ruiz, Montserrat; Calingasan, Noel Ylagan; Villarroya, Francesc; Naudí, Alba; Pamplona, Reinald; Ferrer, Isidre; Beal, M. Flint; Portero‐Otín, Manuel; Fourcade, Stéphane; Pujol, Aurora
• Is Part Of: Neuropathology & applied neurobiology. Volume 48:Number 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-07-29
• Subjects: adrenoleukodystrophy -- mitochondria -- neuroinflammation -- oxidative stress -- RIP140; Nervous system -- Diseases -- Pathology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/nan.12747
• Languages: English
• ISSNs: 0305-1846

Abstract

Abstract: Aims: Mitochondrial dysfunction and inflammation are at the core of axonal degeneration in several multifactorial neurodegenerative diseases, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease. The transcriptional coregulator RIP140/NRIP1 (receptor‐interacting protein 140) modulates these functions in liver and adipose tissue, but its role in the nervous system remains unexplored. Here, we investigated the impact of RIP140 in the Abcd1 − mouse model of X‐linked adrenoleukodystrophy (X‐ALD), a genetic model of chronic axonopathy involving the convergence of redox imbalance, bioenergetic failure, and chronic inflammation. Methods and results: We provide evidence that RIP140 is modulated through a redox‐dependent mechanism driven by very long‐chain fatty acids (VLCFAs), the levels of which are increased in X‐ALD. Genetic inactivation of RIP140 prevented mitochondrial depletion and dysfunction, bioenergetic failure, inflammatory dysregulation, axonal degeneration and associated locomotor disabilities in vivo in X‐ALD mouse models. Conclusions: Together, these findings show that aberrant overactivation of RIP140 promotes neurodegeneration in X‐ALD, underscoring its potential as a therapeutic target for X‐ALD and other neurodegenerative disorders that present with metabolic and inflammatory dyshomeostasis. Abstract : This study reports that RIP140 is upregulated in the CNS of the X‐ALD mouse model and most severe cALD patients. RIP140 induction is mediated by excess hexacosanoic acid, diagnostic disease hallmark, through a redox‐dependent mechanism involving mitochondrial ROS production. In turn, RIP140 ignites a proinflammatory response including TNFa, reported to produce mitochondrial ROS, in a "vicious circle" situation which may apply to other neurodegenerative or metabolic diseases. Ablation of RIP140 in X‐ALD mice protects against mitochondrial and bioenergetic failure and chronic inflammation, thus preserving axonal health.